Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Influenza

Free Subscription 15.12.2025 2 Biochem Biophys Res Commun 2 Cell 2 Epidemiol Infect 1 J Epidemiol Community Health 1 J Exp Med 1 J Gen Virol 1 J Immunol 1 J Infect 1 J Infect Dis 1 J Neurosurg Pediatr 1 J Virol 4 J Virol Methods 2 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 1 PLoS Biol 3 PLoS Comput Biol 21 PLoS One 28 Vaccine 1 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. HU J, Li J, You W, Liu L, et al
   Disruption of the local vRNA structure at the end of HA encoding region interferes with the selective packaging of influenza A virus genome.
   Biochem Biophys Res Commun. 2025;795:153082.
   PubMed         Abstract available
   
   
2. BANGARU MLY, Raghavendra NK
   Helix alpha1 of human ACE2 mimics dsDNA and Spike of SARS-CoV-2 binds DNA.
   Biochem Biophys Res Commun. 2025;793:153020.
   PubMed         Abstract available
   
   

   
   Cell

3. WASDIN PT, Johnson NV, Janke AK, Held S, et al
   Generation of antigen-specific paired-chain antibodies using large language models.
   Cell. 2025;188:7206-7221.
   PubMed         Abstract available
   
   
4. YAN L, Huang Y, Liu Y, Ge J, et al
   Structural basis for the concurrence of template recycling and RNA capping in SARS-CoV-2.
   Cell. 2025;188:7194-7205.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

5. ASPLIN P, Fyles M, Kennedy J, Ward T, et al
   Evaluating Google Trends as a proxy for symptom incidence: insights from the winter COVID-19 infection study in England 2023/24.
   Epidemiol Infect. 2025;153:e136.
   PubMed         Abstract available
   
   
6. MUNCH PK, Hansen CH, Moller FT, Norgaard SK, et al
   COVIDmeter - a questionnaire-based symptom monitoring system for the surveillance of COVID-19 in Denmark, 2020-2023.
   Epidemiol Infect. 2025;153:e134.
   PubMed         Abstract available
   
   

   
   J Epidemiol Community Health

7. ZHAO M, Yang L, Cheng P, Schwebel D, et al
   Helmet use among cyclists and motorcyclists involved in media-reported road traffic crashes after implementation of the national 'One Helmet, One Belt' campaign in China.
   J Epidemiol Community Health. 2025;80:35-40.
   PubMed         Abstract available
   
   

   
   J Exp Med

8. ZHANG Q, Conrad TS, Moncada-Velez M, Jiang K, et al
   Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza.
   J Exp Med. 2026;223:e20251962.
   PubMed         Abstract available
   
   

   
   J Gen Virol

9. VAN DIEMEN PM, Ramsay AM, Everett HE, Hurley S, et al
   Experimental infection of alpacas (Vicugna pacos) with influenza C or D viruses results in subclinical upper respiratory tract disease.
   J Gen Virol. 2025;106.
   PubMed         Abstract available
   
   

   
   J Immunol

10. ALBE JR, Chaudhary A, Khanna A, Weinstein K, et al
    Divergent effects of a Treg-selective IL-2 mutein on influenza-specific T cell responses.
    J Immunol. 2025 Dec 10:vkaf297. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect

11. KITANO T, Tsuzuki S, Fukuda H, Yoshida S, et al
    Long-term impact of nirsevimab on prevention of respiratory syncytial virus infection using a real-world global database.
    J Infect. 2025;91:106652.
    PubMed         Abstract available
    
    

    
    J Infect Dis

12. DAULAGALA P, Leung YWY, Luk LLH, Ho F, et al
    Anti-neuraminidase antibody responses in older adults after consecutive vaccinations with enhanced influenza vaccines: a randomized controlled trial.
    J Infect Dis. 2025 Dec 8:jiaf616. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurosurg Pediatr

13. GELMAN K, Fletcher D, Li H, Wen S, et al
    The use of telehealth in pediatric neurosurgery for rural patients of Appalachia.
    J Neurosurg Pediatr. 2025;36:755-763.
    PubMed         Abstract available
    
    

    
    J Virol

14. KAR J, Hirohama M, Nakayama K, Lee S, et al
    Microtubule detyrosination links inflammasome activation to apoptotic cell death in macrophages upon influenza A virus infection.
    J Virol. 2025 Dec 9:e0184725. doi: 10.1128/jvi.01847.
    PubMed         Abstract available
    
    

    
    J Virol Methods

15. JAASKELAINEN AE, Pitkaranta A, Haaramo A, Nokso-Koivisto J, et al
    Saliva samples in SARS-Cov-2 virus detection compared to the nasopharyngeal RT-PCR findings in individuals with suspected COVID-19 infection.
    J Virol Methods. 2026;340:115295.
    PubMed         Abstract available
    
    
16. MORWITZER MJ, Zheng YY, Friberg H, Currier JR, et al
    A split GFP approach to assay SARS-CoV-2 spike-dependent cell fusion.
    J Virol Methods. 2026;340:115296.
    PubMed         Abstract available
    
    
17. THIBAUT J, Gambaro F, Geenen C, Hong SL, et al
    A novel methodology for assessing contact tracing precision: Phylogenetic validation of a contact tracing program for COVID-19 in Belgium.
    J Virol Methods. 2026;340:115279.
    PubMed         Abstract available
    
    
18. GOSWAMI P, Chatterjee D, Ghosh S, Paira K, et al
    Ultra-diluted Bryonia alba extract modulates HMOX-1 gene expression to attenuate the pathogenetic effect of SARS-CoV-2 spike protein RBD antigen.
    J Virol Methods. 2026;340:115274.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

19. IRVING SA, Rowley EAK, Chickery S, Natarajan K, et al
    Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:607-614.
    PubMed         Abstract available
    
    
20. ZAMBRANO LD, Simeone RM, Newhams MM, Payne AB, et al
    Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:580-588.
    PubMed         Abstract available
    
    

    
    N Engl J Med

21. NEUZIL KM
    Current and Emerging Approaches to Evaluating Influenza Vaccine Performance.
    N Engl J Med. 2025;393:2361-2362.
    PubMed        
    
    

    
    PLoS Biol

22. STERTZ S, Karakus U
    A new path to spillover: MHC-II entry of influenza A viruses.
    PLoS Biol. 2025;23:e3003550.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

23. MORRIS DJ, Kennedy L, Black AJ
    Random time-shift approximation enables hierarchical Bayesian inference of mechanistic within-host viral dynamics models on large datasets.
    PLoS Comput Biol. 2025;21:e1013775.
    PubMed         Abstract available
    
    
24. LEFEBVRE A, Marechal V, Gloaguen A, Lambert A, et al
    Unsupervised detection and fitness estimation of emerging SARS-CoV-2 variants: Application to wastewater samples (ANRS0160).
    PLoS Comput Biol. 2025;21:e1013749.
    PubMed         Abstract available
    
    
25. PINERO S, Li X, Liu L, Li J, et al
    Integrative multi-omics framework for causal gene discovery in Long COVID.
    PLoS Comput Biol. 2025;21:e1013725.
    PubMed         Abstract available
    
    

    
    PLoS One

26. PICARD-MEYER E, Wasniewski M, Boue F, Torres-Maravilla E, et al
    Lung infection in orally inoculated SARS-CoV-2 hamsters.
    PLoS One. 2025;20:e0337915.
    PubMed         Abstract available
    
    
27. HUSSEIN M, Gebreal A, Naeem A, AboElela AM, et al
    Cross-national disparities in healthcare workers' perceptions: Examining fear of infection and confidence in the received COVID-19 vaccines amid emerging variants.
    PLoS One. 2025;20:e0318788.
    PubMed         Abstract available
    
    
28. LU X, Duan Y
    Channels and countermeasures of the COVID-19 pandemic's impact on urban economic resilience: Lessons from China.
    PLoS One. 2025;20:e0338499.
    PubMed         Abstract available
    
    
29. CAO T, Pan W, Liang Z, Quan J, et al
    Investigation of the effect and mechanisms of moxa smoke in the treatment of Influenza A Virus (IAV) infection.
    PLoS One. 2025;20:e0337906.
    PubMed         Abstract available
    
    
30. SMIT PW, Man P, Brand H, Breijer S, et al
    Comparative evaluation of five rapid PCR platforms for respiratory virus detection.
    PLoS One. 2025;20:e0338716.
    PubMed         Abstract available
    
    
31. ABBASIZANJANI H, Bedston S, Akbari A
    Creating a Research-Ready Data Asset version of primary care data for Wales and investigating the impact of COVID-19 on utilisation of primary care services.
    PLoS One. 2025;20:e0338652.
    PubMed         Abstract available
    
    
32. YANG Y, Liang R, Luo Y, Zhu D, et al
    Investigation on the knowledge-attitude-practice of medical students in controlling emerging infectious diseases: A case study of COVID-19.
    PLoS One. 2025;20:e0338708.
    PubMed         Abstract available
    
    
33. JANKOWSKI JM, Sik K, Job V
    The relationship between lay beliefs about the world and pandemic-related beliefs, attitudes, and behaviors.
    PLoS One. 2025;20:e0338367.
    PubMed         Abstract available
    
    
34. SADEH S, Ghaemi A, Soleimani NA, Moghbeli M, et al
    Designing influenza virus-derived cell-penetrating peptides for antigen delivery: Integrating uptake efficiency, safety, and receptor targeting.
    PLoS One. 2025;20:e0338028.
    PubMed         Abstract available
    
    
35. TUFON KA, Foumene TP, Esembeson M, Bolimo AF, et al
    Trends and factors associated with pneumonia mortality at Buea Regional Hospital in Cameroon from 2020 to 2023.
    PLoS One. 2025;20:e0313234.
    PubMed         Abstract available
    
    
36. MARINDA E, Naidoo Y, Magampa M, Pindo A, et al
    Changes in quality of life over time through the lens of young people aged 18-24 in 2016 in Gauteng Province of South Africa.
    PLoS One. 2025;20:e0338312.
    PubMed         Abstract available
    
    
37. CARNEY-KNISELY G, Pek J, Ferketich AK, Padamsee TJ, et al
    Depression and anxiety mediate the relationship between COVID-19 stay-at-home orders and tobacco and marijuana use.
    PLoS One. 2025;20:e0337996.
    PubMed         Abstract available
    
    
38. CONTI S, Pariza P, Wolters A
    A synthetic control evaluation of the use of pulse oximeters in response to the COVID-19 pandemic in England.
    PLoS One. 2025;20:e0337617.
    PubMed         Abstract available
    
    
39. BEGAY RL, Brown HE, Sanderson PR, Harris RB, et al
    Dine traditional medicine use and wellbeing among navajo adults during the COVID-19 pandemic: A cross-sectional study.
    PLoS One. 2025;20:e0337427.
    PubMed         Abstract available
    
    
40. COUDERT JF, Dadachova E, Maignant G, Jonathan S, et al
    Radon exposure and COVID-19 mortality in pre-vaccination period: What links might exist?
    PLoS One. 2025;20:e0337320.
    PubMed         Abstract available
    
    
41. COSTA T
    The impossible confounder: Quantifying the limits of alternative explanations for COVID-19 vaccine effectiveness.
    PLoS One. 2025;20:e0336063.
    PubMed         Abstract available
    
    
42. DIAO YC, Lou MF
    Development and validation of the healthcare provider and family bidirectional digital communication scale.
    PLoS One. 2025;20:e0338410.
    PubMed         Abstract available
    
    
43. GEORGE NA, Bradford L, Hinz A, El Kadi M, et al
    SARS-CoV-2 detection is independent of microbiome composition on surfaces in a major Ontario hospital.
    PLoS One. 2025;20:e0326403.
    PubMed         Abstract available
    
    
44. HUUSKO M, Vuohijoki A, Ristolainen L, Leppilahti J, et al
    Implementation and staff perceptions of a quality assurance system in a finnish private hospital during the COVID-19 Pandemic: A qualitative study.
    PLoS One. 2025;20:e0327271.
    PubMed         Abstract available
    
    
45. PARUBETS S, Naito H
    Predicting economic activity using atmospheric nitrogen dioxide (NO2) satellite data: Evidence from local economic indicators in Japan.
    PLoS One. 2025;20:e0337901.
    PubMed         Abstract available
    
    
46. FUHRMANN V, Tyczynski B, Perez Ruiz de Garibay A, Bingold TM, et al
    The Advanced Organ Support (ADVOS) hemodialysis system fulfills its intended purpose: Analysis of data from 282 patients from the Registry on Extracorporeal Multiple Organ Support (EMOS).
    PLoS One. 2025;20:e0318917.
    PubMed         Abstract available
    
    

    
    Vaccine

47. CASWELL C, Pullenayegum E, Singh P, Ward BJ, et al
    Sex-differences in influenza vaccine efficacy and immunogenicity among Canadian Hutterite children.
    Vaccine. 2025;72:128102.
    PubMed         Abstract available
    
    
48. WALTER EB, Schlaudecker EP, Talaat KR, Rountree W, et al
    Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trial.
    Vaccine. 2025;72:128072.
    PubMed         Abstract available
    
    
49. SONG JY, Cheong HJ
    Understanding the low effectiveness of influenza vaccines in older adults of South Korea: an exploration of contributing factors.
    Vaccine. 2025;71:128076.
    PubMed         Abstract available
    
    
50. MEYER AC, Braegelmann K, Orozco-Ruiz X, Kruppert S, et al
    Comparing uptake of high-dose and standard-dose influenza vaccination at the practice and patient level in Germany.
    Vaccine. 2025;71:128075.
    PubMed         Abstract available
    
    
51. ASKAR M, Adel K, Batke M, Chi Y, et al
    Population effects of influenza vaccination in children and adolescents: Systematic review.
    Vaccine. 2025;71:128040.
    PubMed         Abstract available
    
    
52. RICHARDSON RA, Moon C, Sands CM, Nelson R, et al
    Generation of a shelf-stable, broadly-reactive influenza vaccine formulated with TLR4, TLR7/8, or TLR9 stimulating adjuvants.
    Vaccine. 2025;72:128028.
    PubMed         Abstract available
    
    
53. REEVES C, Miura SST, Chappell AR, Banaag A, et al
    Trends in influenza vaccination uptake in a universally insured population in the united states, 2017-2023.
    Vaccine. 2025;71:128052.
    PubMed         Abstract available
    
    
54. ABBAD A, Lerman B, Ehrenhaus J, Ojeda DS, et al
    Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naive and convalescent populations.
    Vaccine. 2025;70:128018.
    PubMed         Abstract available
    
    
55. KIM SH, Kang MG, Jang JG, Kim Y, et al
    Severe COVID-19, vaccination, and mortality among individuals with asthma: A Nationwide population-based cohort study.
    Vaccine. 2025;70:128017.
    PubMed         Abstract available
    
    
56. HAMMOUD M, Smith AKJ, Sachs O, Bavinton BR, et al
    Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022-2024).
    Vaccine. 2025;70:128041.
    PubMed         Abstract available
    
    
57. LE TOURNEAU N, Sharma A, Pry JM, Haambokoma M, et al
    Drivers of decision-making for future adult vaccines: a best-worst scaling among community members and health care workers in Zambia.
    Vaccine. 2025;70:128003.
    PubMed         Abstract available
    
    
58. DEV AS, Broos HC, Llabre MM, Saab PG, et al
    Examining the independent and interactive roles of intolerance of uncertainty in vaccination intent.
    Vaccine. 2025;70:128008.
    PubMed         Abstract available
    
    
59. HUANG O, Tan BF, Lu CY
    Taiwanese parental perspectives on RSV: knowledge, risks, and acceptance toward immunization.
    Vaccine. 2026;70:128005.
    PubMed         Abstract available
    
    
60. PICHE-RENAUD PP, Buchan CA, Burton C, Chapdelaine H, et al
    Revaccination of individuals with cardiac adverse events following COVID-19 vaccination: A Canadian Immunization Research Network study.
    Vaccine. 2025;70:128016.
    PubMed         Abstract available
    
    
61. CHAU SL, Hung IFN, Luk TT, Chan SSC, et al
    The impacts of long COVID and booster doses of post-infection vaccination among hospital-discharged COVID-19 survivors in Hong Kong: A retrospective observational study.
    Vaccine. 2025;70:128022.
    PubMed         Abstract available
    
    
62. CHAZARIN B, Bhat AS, Sundararaman N, Liu Y, et al
    Longitudinal proteomic and autoantibody signatures after mRNA vaccination in healthy individuals.
    Vaccine. 2025;70:127888.
    PubMed         Abstract available
    
    
63. VAHABI MM, Ketentzi S, Kahraman U, Erdem HA, et al
    A single center's 25-year experience with hepatitis B and pneumoccocal vaccines in heart transplant patients: the impact of the COVID-19 pandemic.
    Vaccine. 2025;70:128023.
    PubMed         Abstract available
    
    
64. VANASSE LT, Safdar B, Self WH, Zhu Y, et al
    Comparison of immunization information systems, electronic medical records, and self-report to ascertain RSV vaccination status among US adults aged >/=60 years, 2023-2024.
    Vaccine. 2025;69:127946.
    PubMed         Abstract available
    
    
65. LASRADO N, Rossler A, McConnell I, Molloy K, et al
    Immunogenicity of JN.1 and KP.2 COVID-19 mRNA vaccines against emerging SARS-CoV-2 variants.
    Vaccine. 2025;69:127997.
    PubMed         Abstract available
    
    
66. SCHUH HB, Delamater P, Proveaux TM, Dudley MZ, et al
    In a shifting policy era: California provider knowledge and practice of medical exemption laws during the COVID-19 pandemic.
    Vaccine. 2026;69:127993.
    PubMed         Abstract available
    
    
67. CRAMER EY, Dada AO, Onofrey S, Pearlman J, et al
    Population-based serosurveys for SARS-CoV-2 transmission 2021-2022, Massachusetts USA.
    Vaccine. 2026;69:127952.
    PubMed         Abstract available
    
    
68. ILBOUDO DP, Simpore A, Sawadogo J, Ouattara AK, et al
    Acceptance, hesitancy, and ethical challenges of the COVID-19 vaccine in sub-Saharan Africa: a systematic review and meta-analysis.
    Vaccine. 2025;69:127966.
    PubMed         Abstract available
    
    
69. MARTINEZ-PEREZ A, Galvez RI, Grifoni A, Sette A, et al
    Impact of the bivalent COVID-19 booster on spike-specific t cell responses.
    Vaccine. 2026;69:127995.
    PubMed         Abstract available
    
    
70. RAUPACH J, Housria Y, Hein S, Schnierle B, et al
    Comparative analysis of a flexible novel vaccine platform based on cell permeable chimeric HBV capsids for mucosal vaccination.
    Vaccine. 2025;69:127987.
    PubMed         Abstract available
    
    
71. CHAPMAN S, Christodoulaki ME, Davey SA, Gaffiero D, et al
    Understanding vaccine hesitancy: The role of fear and message framing in COVID-19 vaccination intention in adults in the UK.
    Vaccine. 2025;69:127999.
    PubMed         Abstract available
    
    
72. LEDDERER L, Nielsen KH, Skodborg L, Fage-Butler A, et al
    Public trust and mistrust of COVID-19 vaccines: A systematic meta-narrative review.
    Vaccine. 2025;69:127947.
    PubMed         Abstract available
    
    
73. GRASSI CM, Feng J, Wahid R, Kandinov B, et al
    Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants.
    Vaccine. 2025;69:127960.
    PubMed         Abstract available
    
    
74. RANA MM, Haydel B, Carrara G, Gleason C, et al
    Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV.
    Vaccine. 2025;69:127969.
    PubMed         Abstract available
    
    

    
    Virology

75. BRICE DC, Andreev K, Miller L, Patton C, et al
    Immunogenicity and efficacy of commercial poultry avian influenza vaccines against HPAI A(H5N1) clade 2.3.4.4b viruses in Mexico.
    Virology. 2025;615:110765.
    PubMed         Abstract available
    
    

    
    Virus Res

76. LUO L, Lv J
    Stochastic mutation as a mechanism for the emergence of SARS-CoV-2 new variants.
    Virus Res. 2025;362:199667.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.